bioRxivCancer BiologyPreprint
Metabolic reprogramming and elevation of glutathione in chromophobe renal cell carcinomas
Y. Xiao, R. Clima, J. F. Busch, A. Rabien, E. Kilic, S. Villegas, S. Tuerkmen, B. Timmermann, M. Attimonelli, K. Jung, D. Meierhofer
Abstract
Chromophobe renal cell carcinomas (chRCC) are derived from intercalated cells of the collecting duct system, and are thought to be the malignant counterpart of benign renal oncocytomas. Here, we report the characterization of nine chRCC with adjacent healthy kidney tissues by applying proteome-, transcriptome (TCGA)-, and metabolome profiling. Most strikingly, the reactive oxygen species scavenger glutathione was significantly elevated in chRCC, caused by down-regulated enzymes involved in glutathione degradation. Metabolic reprogramming including stalled gluconeogenesis, down-regulated fatty acid- and amino acid metabolism was identified, even though, the abundance of amino acids and \"energy carrier\" molecules were unchanged. A striking anti-correlation of the mitochondrial respiratory chain between the transcriptome and the proteome was discovered, the transcripts coding for the respiratory chain were up-, while corresponding proteins and enzymatic activities were down-regulated. Similar to renal oncocytomas, chRCC exhibited a significant increase in glutathione, but are distinguishable by distinct regulation of the respiratory chain.
- organism: human
- assay: proteomics
- assay: metabolomics
- assay: bulk RNA-seq
- research focus: metabolism & bioenergetics
- research focus: cell type annotation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Papillary renal cell carcinomas rewire glutathione metabolism and are deficient in anabolic glucose synthesis
A. Alahmad, V. Paffrath, … D. Meierhofer·bioRxiv·May 27, 2019
- Copper drives remodeling of metabolic state and progression of clear cell renal cell carcinoma
M. Czyzyk-Krzeska, M. E. Bischoff, … J. T. Cunningham·bioRxiv·Jan 16, 2024
- In-vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinoma
A. Kaushik, L. K. Burroughs, … R. J. DeBerardinis·bioRxiv·Oct 31, 2022
- Profilin-1 Promotes Chromophobe Renal Cell Carcinoma Malignancy
Kaylee M. Montanari, Anup Acharya, … David M. Gau·bioRxiv·May 14, 2026
- TGF-B signaling suppresses TCA cycle metabolism in renal cancer.
H. Nam, A. Kundu, … S. Sudarshan·bioRxiv·Feb 19, 2021
- CHPF boosts proliferation and invasion of clear cell renal cell carcinoma
Yaoyu Zhang, Xiaowei Li, … Shadan Li·bioRxiv·Jun 9, 2023